VC-backed oncology company Aura Biosciences goes public
Aura Biosciences, a Cambridge, Massachusetts-based oncology company, has raised $75.6 million for its IPO after pricing its 5.4 million shares at $14 per share.
Aura Biosciences, a Cambridge, Massachusetts-based oncology company, has raised $75.6 million for its IPO after pricing its 5.4 million shares at $14 per share.
Copyright PEI Media
Not for publication, email or dissemination